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The benefits and risks of endomyocardial biopsy in infants,
chHdren and adolescents were determined by reviewing the
indications for and complications and results of 66 proce-
dure~in 53 patients aged 2 months to 20 years. One patient
had a pneumothorax, and three had a right ventricular
perforation. Ventricular tac~ycardia developed in four
patients; it was treated with lidocaine in three and was
self-limited in one. The procedure was uJlsuccessful in two
patients.
Among 25 patients with a prebiopsy diagnosis of idio-
pathic dilated cardiomyopathy, microscopic features were
consistent with cardiomyopathy in' 24 (%%) and were
normal in 1. Of nine patiellts with clinically suspected
myocarditis, only two (2~%) had microscopic evidence of
inflammation, and seven had chronic nonspecific features
suggestive of dilated cardiomyopathy. Of eight patients
with unexplained arrhythmias, six (75%) had microscopic
In adults, the utility of endomyocardial biopsy has been
established for the diagnosis of acute cardiac transplant
rejection, anthracycline cardiotoxicity, myocarditis and cer-
tain secondary forms of cardiac disease, including amyloi-
dosis, hemochromatosis, sarcoidosis and various storage
diseases (1,2). Moreover, it may be useful for the evaluation
of dilated, hypertrophic and restrictive forms of cardiomy-
opathy, as well as atypical chest pain and idiopathic arrhyth-
mias (1,2). The clinical role of endomyocardial biopsy in
infants, children and adolescents, however, is less well
established (3-16). The purpose of this study was to assess
the usefulness and complications of endomyocardial biopsy
in this age group.
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findings compatible with dilated cardiomyopathy and two
had myocarditis. Biopsy tissue samples from seven patients
with nondilated forms of cardiomyopathy (four hyper-
trophic, three restrictive) were consistent with the clinical
diagnosis in six and were inadequate in one. Cardiac
biopsies were also performed in four patients with other
disorders. Among the 51 patients with adequate biopsy
specimens, microscopic features were considered diagnostic
in 5, confirmatory in 44 and not helpful in 2 with normal
tissue.
The results indicate that endomyocardial biopsy is safe
in infants, children and adolescents. It is useful for the
evaluation of cardiomyopathy and specific secondary forms
of myocardial disease. There seems to be little correlation,
however, betWeen clinical and tissue diagnoses of myocardi-
tis.
(J Am Coli CardioI1990;15:436-42)
Methods
Study group. During the decade from January 1978 to
December 1987, 66 transvenous endomyocardial biopsy pro-
cedures were performed at our institutipn in 53 patients aged
::520 years. These cases form the stu4Y group, and demo-
graphic data,including a patient's ag~, gender and cardio-
vascular diagnoses, were obtained from a review of medical
charts. Endomyocardial biopsies were performed as de-
scribed by others (6,8,13,17-19), and all specimens were
processed routinely for light microscopy. Additional studies
in selected cases included transmission electron microscopy,
immunofluorescence microscopy and viral cultures.
Diagnostic biopsy criteria. Certain chronic nonspecific
biopsy features were considered to be consistent with car-
diomyopathy if appreciable ischemic, valvular, hypertensive
and toxic forms of heart disease were excluded clinically (1).
These features included myocyte hypertrophy, with or with-
out degenerative changes or attenuation, and proliferation or
fibrosis of the myocardial interstitium or endocardium. The
diagnosis of lymphocytic myocarditis was established with
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Patients
Table 1. Age Distribution of 53 Patients Undergoing
Endomyocardial Biopsy
the Dallas criteria (20,21) and required the presence of an
inflammatory infiltrate and evidence of adjacent myocyte
injury or necrosis. According to these criteria, the presence
of an inflammatory infiltrate without myocyte damage was
labeled borderline myocarditis.
Results
General clinical features. Of the 53 patients, 33 were male
and 20 were female. Their ages ranged from 2 months to 20
years; 75% were older than 10 years and 51% were older
than 15 years (Table 1). For the entire group, the mean age
was 13 years (Table 2) and the median age was 16 years. The
most commonly recorded clinical features were heart failure,
arrhythmias and chest pain (Tables 2 and 3).
Heart disease was familial in five patients, including three
with dilated cardiomyopathy and two with hypertrophic
cardiomyopathy. Six patients had congenital heart disease,
including one case each of Ebstein's anomaly, combined
aortic stenosis and insufficiency, bicuspid aortic valve,
patent ductus arteriosus, repaired secundum atrial septal
defect and complete heart block.
Technical features. Two patients with dilated cardiomy-
opathy and three with a prebiopsy diagnosis of myocarditis
underwent two biopsy procedures each. Among eight pa-
tients with idiopathic arrhythmias, two had two biopsies
each and two had four biopsies each. Thus, 66 procedures
were performed in the 53 patients; 56 were right ventricular
and 10 were left ventricular. Entry sites included the right
internal jugular vein in 43 cases, the right femoral vein in 19
and the right femoral artery in 4.
The number of biopsy specimens per case ranged from 1
to 10 (mean 5) (Table 4). Adequate tissue for diagnosis was
obtained in 64 (97%) of the 66 procedures and in 51 of the 53
patients. The biopsy tissue was considered inadequate in a
15 year old patient with hypertrophic cardiomyopathy (one
specimen) and in an 18 year old patient with old myocardial
infarction (three specimens, all endocardial).
Complications. A 17 year old patient whose right internal
jugular vein was entered developed a right pneumothorax 24
h after biopsy and was treated with thoracostomy tube
drainage. The biopsy procedure was complicated by perfo-
ration of the right ventricle with the bioptome or transvenous
sheath in three patients (aged 6 months, 11 months and 2
years, respectively). In all three, the procedure was per-
formed from the right leg with use of a preformed sheath for
bioptome placement. In two, the resulting hemopericardium
was treated by pericardiocentesis and autotransfusion. In
one, a small pneumopericardium occurred but required no
intervention.









I to 5 6
6 to 10 3
II to 15 13
16 to 20 27
Table 2. Clinical Features of 53 Patients Undergoing Endomyocardial Biopsy
Prebiopsy Clinical Diagnosis
Dilated CM Myocarditis Arrhythmia HCM RCM Other Total
Feature (n = 25) (n = 9) (n = 8) (n = 4) (n = 3) (n = 4) (n = 53)
Age (yr)
Mean 12 16 14 9 10 17 13
Range 0.5 to 19 2 to 20 6 to 20 0.2 to 18 2 to 14 12 to 20 0.2 to 20
Gender (no.)
Male 17 6 4 2 2 2 33
Female 8 3 4 2 I 2 20
Male/female ratio 2.1 2.0 1.0 1.0 2.0 1.0 1.7
Symptoms/signs (no.)
Heart failure 13 3 0 0 3 0 19
Arrhythmia 13 5 8 0 I I 28
Chest pain 5 4 I 0 0 I 11
Investigation (no.)
Cardiac cath 20 6 5 4 3 3 41
Echocardiography 19 7 5 4 3 4 42
Both 15 4 5 4 3 3 34
Neither I 0 3 0 0 0 4
Cath = catheterization; CM = cardiomyopathy; HCM = hypertrophic cardiomyopathy; no. = number of patients; RCM = restrictive cardiomyopathy.
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Table 3. Types of Rhythm Disturbances in 53 Patients Undergoing Endomyocardial Biopsy
Prebiopsy Clinical Diagnosis (no. of patients)
Dilated Total No. of
Disturbance CM Myocarditis Arrhythmia HCM RCM Other Patients
Ventricular tachycardia 1 3 7 0 0 0 II
Ventricular premature complexes 6 0 0 0 0 1 7
Supraventricular tachycardia 3 0 0 0 1 0 4
Atrial fibrillation 0 0 I 0 0 0 1
Atrial premature complexes 0 1 0 0 0 0 1
Congenital CHB 1 0 0 0 0 0 1
Long QT interval 1 0 0 0 0 0 1
Tachybradycardia 1 0 0 0 0 0 1
Vasovagal syncope 0 1 0 0 0 0 I
Total 13 5 8 0 1 1 28
CHB = complete heart block; other abbreviations as in Table 2.
(mean 12 years); 17 (68%) were male. Heart failure and
arrhythmias were the most common clinical manifestations
(Tables 2 and 3).
Cardiomyopathy was biventricular in 22 patients and
predominantly affected the right ventricle in 3. Associated
findings included endocardial fibroelastosis in two patients
and muscular dystrophy, Ebstein's anomaly, bicuspid aortic
valve, congenital aortic stenosis and insufficiency and con-
genital complete heart block in one patient each.
Among the 25 patients, the indications for biopsy in-
cluded confirmation of cardiomyopathy in 14 and evaluation
for possible myocarditis in II. Microscopic features consist-
ent with cardiomyopathy were present in 24 (96%) of the 25
patients (Table 5) and were mild in 18 and moderate in 6. In
one patient, the biopsy tissue samples were histologically
normal. None of the patients had biopsy evidence of myo-
carditis.
Six (24%) of the 25 patients with dilated cardiomyopathy
have since died, four of heart failure and two after cardiac
transplantation. Autopsy tissue samples from two patients
had evidence of chronic recurrent myocarditis, although
biopsy tissue samples had not shown myocarditis in either
case.
Hypertrophic cardiomyopathy. The ages of the four pa-
tients with hypertrophic cardiomyopathy ranged from 2
months to 18 years (mean 9 years); two were male and two
were female. The clinical manifestation in each patient was a
cardiac murmur. Biopsy features were consistent with car-
diomyopathy in three patients (Table 5) and were mild in one
and moderate in two. In the fourth patient, who was 15 years
old, only one small biopsy specimen was obtained and it was
considered inadequate for diagnosis. The youngest patient
has since died of aspiration pneumonia, and the other three
were still alive.
Restrictive cardiomyopathy. The ages of the three pa-
tients with restrictive cardiomyopathy ranged from 2 to 14
years (mean 10); two patients were male and one was female.
Procedure
Table 4. Distribution of Number of Specimens Obtained in 66
Endomyocardial Biopsy Procedures
No. of Specimens











9, 12, 14 and 17 years). In three patients, all of whom had a
clinical history of recurrent ventricular tachycardia, the
arrhythmia was treated with lidocaine. Tachycardia was self-
limited in the fourth patient, who had a history of a long QT
interval and ventricular premature complexes.
Cardiomyopathy. Thirty-two (60%) of the 53 patients
were diagnosed clinically as having cardiomyopathy (dilated
in 25, hypertrophic in 4, restrictive in 3). The disorder was
familial in five cases (dilated in three, hypertrophic in two).
No patient with restrictive cardiomyopathy had a family
history of the disease, and none had evidence of peripheral
eosinophilia.
Hypertrophy and fibrosis were the most commonly ob-
served abnormalities in biopsy tissue and were considered to
be consistent with cardiomyopathy. Myofiber disarray was
no more extensive in patients with hypertrophic cardiomy-
opathy than in those with dilated or restrictive disease.
Although only 32 cases had a clinical diagnosis of cardiomy-
opathy, 44 (83%) of the 53 patients had biopsy features
suggestive of cardiomyopathy (Table 5).
Dilated cardiomyopathy. The ages of the 25 patients with
dilated cardiomyopathy ranged from 6 months to 19 years
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Table 5. Comparison of Prebiopsy and Postbiopsy Diagnoses in 53 Patients Undergoing Endomyocardial Biopsy
Prebiopsy Clinical Diagnosis (no. of patients)
Postbiopsy Dilated Total No. of
Diagnosis CM Myocarditis Arrhythmia HCM RCM Other Patients
Cardiomyopathy 24 7 6 3 3 I 44
Myocarditis 0 2 2 0 0 0 4
Normal I 0 0 0 0 1 2
Other 0 0 0 I 0 2 3
Total 25 9 8 4 3 4 53
Abbreviations as in Table 2.
All three had clinical features of heart failure, and one had
arrhythmias on Holter electrocardiographic (ECG) monitor-
ing. Abnormalities in the biopsy tissue were consistent with
cardiomyopathy in all three patients (Table 5) and were mild
in two and moderate in one. There was no history of
peripheral eosinophilia, and no eosinophils were observed in
the biopsy tissue samples.
The youngest patient has since died suddenly. At au-
topsy, the heart was characterized by small ventricular
chambers with no evidence of disproportionate septal thick-
ening. Myofiber disarray of mild to moderate extent, how-
ever, was observed throughout the ventricular myocardium
and suggested that this patient had an atypical form of
hypertrophic cardiomyopathy.
Myocarditis. Clinically, nine patients were thought to
have primary myocarditis. Their ages ranged from 2 to 20
years (mean 16); six were male and three were female.
Among the nine patients, five had arrhythmias, four had
chest pain, three had heart failure and two were febrile
(Tables 2 and 3). Biopsy tissue samples were negative for
myocarditis in both patients with fever. In seven (78%) of the
nine patients, the biopsy features were consistent with
cardiomyopathy rather than myocarditis (Table 5) and were
mild in five and moderate in two. In one patient, a 20 year old
man, arrhythmogenic right ventricular dysplasia was subse-
quently diagnosed on the basis of biopsy and clinical find-
ings.
Only two (22%) ofthe nine patients had biopsy specimens
that were positive for myocarditis. One patient, a 19 year old
man with mild lymphocytic myocarditis, received no immu-
nosuppressive therapy and is currently asymptomatic with
no cardiac dysfunction. The other patient, a 17 year old man
with mild lymphocytic myocarditis, had a history of drug
abuse (alcohol, marijuana, cocaine and amphetamines), and
the myocarditis was presumed to be drug-related.
Among the 16 patients with a prebiopsy diagnosis other
than myocarditis (dilated cardiomyopathy in II and unex-
plained arrhythmias in 5) but in whom a cardiac biopsy was
performed to rule out myocarditis, an inflammatory infiltrate
was detected in 2 (13%). A 9 year old girl with syncope and
multifocal ventricular tachycardia had mild lymphocytic
myocarditis. Although the arrhythmia persisted, results of
three subsequent heart biopsies were normal. The patient
subsequently died suddenly and unexpectedly, but no au-
topsy was performed. The second patient, a 17 year old man
with ventricular tachycardia and a past history of drug
abuse, had borderline myocarditis associated with a mixed
nongranulomatous inflammatory infiltrate of neutrophils,
eosinophils and lymphocytes. A subsequent heart biopsy
demonstrated abnormalities consistent with cardiomyopa-
thy, concordant with the clinical impression.
Unexplained arrhythmias. The ages of the eight patients
with unexplained arrhythmias ranged from 6 to 20 years
(mean 14); four patients were male and four were female
(Table 2). Seven of these patients had ventricular tachycar-
dia, four of whom had syncope and one had chest pain
(Table 3). One patient had atrial fibrillation associated with
mitral valve prolapse. Two underwent electrophysiologic
studies, and one had Holter ECG monitoring.
Biopsy procedures were performed to exclude the diag-
nosis of myocarditis in five patients (only one of whom had
myocarditis in biopsy tissue), to investigate a possible myo-
cardial cause of the arrhythmia in two and to detect changes
consistent with cardiomyopathy in one (whose biopsy result
showed myocarditis). In six of the eight patients, biopsy
features were consistent with cardiomyopathy (Table 5), and
the changes were mild in all six. Of the remaining two
patients, one had lymphocytic myocarditis and the other had
borderline myocarditis (see earlier).
Other disorders. A 12 year old boy had idiopathic chest
pain and a slightly dilated right ventricle echocardiographi-
cally. Biopsy tissue samples were normal.
A 17 year oLd woman with synoviaL ceLL sarcoma had
changes of grade 2 doxorubicin (Adriamycin) cardiotoxicity
in the biopsy tissue. She subsequently died of heart failure
due to doxorubicin cardiotoxicity and viral myocarditis.
An 18 year old woman had evidence of oLd inferior and
inferolateraL myocardial infarctions and had premature ven-
tricular complexes. At cardiac catheterization, her coronary
arteries appeared normal, and results of ergonovine study
were negative. There was no history of drug abuse. Three
biopsy samples were obtained and consisted only of fibrotic
440 YOSHIZATO ET AL.
ENDOMYOCARDIAL BIOPSY IN CHILDREN
lACC Vol. 15, No.2
February 1990:436-42
Table 6. Summary of Reported Series of Endomyocardial Biopsies in Infants, Children and Adolescents, 1977-1989
Prebiopsy Clinical Diagnosis (no. of patients)
Age of Gender Dilated
Reference Year Patients (male/female) CM Myocarditis Arrhythmia HCM RCM Other Total
MacKay et aI. (3) 1977 5 mo to 15 yr 10/5 0 0 3 3 0 9 15
Fujita et aI. (4) 1979 4mot05yr 7/3 9 0 0 I 0 0 10
Yutani et al. (5) 1981 ImotoIIyr 138/63 0 0 0 0 0 201* 201
Schmaltz et aI. (6) 1982 I mo to 17 yr 3 I 0 4 0 6 14
Takahashi et aI. (7) 1983 4 to 14 yr 4/4 0 8 0 0 0 0 8
Rios et aI. (8) 1984 7 mo to 12 yr 10 5 I 0 0 2 18
Pegelow et aI. (9) 1984 3 to 18 yr 0 0 0 0 0 13t 13
Lewis et aI. (10) 1985 1 mo to 15 yr 10/5 15 0 0 0 0 0 15
Mortensen et aI. (11) 1986 7 to 16 yr 3/0 0 0 0 3 0 0 3
Saji et aI. (12) 1986 5 to 12 yr 5/3 0 8 0 0 0 0 8
Bhargava et aI. (13) 1987 6 mo to 19 yr 0 0 0 0 0 7t 7
Schmaltz et aI. (14) 1987 2 mo to 17 yr 8/5 13 0 0 0 0 0 13
Chandra (15) 1987 2 mo to 15 yr 14/12 17 3 0 4 1 1 26
Leatherbury et aI. (16) 1988 2 mo to 15 yr 10/10 16 2 0 2 0 0 20
Present study 1990 2mot020yr 33/20 25 9 8 4 3 4 53
*Kawasaki's disease (mucocutaneous lymph node syndrome); tanthracycline cardiotoxicity; tcardiac allograft rejection. Abbreviations as in Table 2.
endocardium. Because no myocardium was available for
evaluation, the biopsy tissues were considered inadequate
for diagnosis.
A 20 year old man had a history of familial carnitine
palmitoyl transferase deficiency. Light microscopy of biopsy
tissue showed mild changes of hypertrophy and fibrosis, and
transmission electron microscopy demonstrated nonspecific
mitochondrial degenerative changes.
Discussion
Although transvascular endomyocardial biopsy was de-
scribed in children in 1978 (17), only a few series (3-16) of
cases have since been published (Table 6). Except for one
report of the biopsy features in 201 children with Kawasaki's
disease (5), the remaining series have each contained <30
cases. In the current investigation, results were presented
for 66 biopsy procedures in 53 patients.
Safety and usefulness of biopsy procedure. Endomyocar-
dial biopsy procedures have been performed safely and
successfully in patients as young as 1 month (5,6,10). Al-
though ventricular premature complexes frequently occur
during manipulation of the bioptome within the right ventri-
cle (17,18), serious complications are rare, even when mul-
tiple serial biopsy procedures are performed (13,22). In fact,
no complications were observed in several series (6,8,13,16).
De Moor and Human (18) reported transient bradycardia
in 2 of 10 patients. Transient myocardial ischemia developed
during left ventricular biopsy in 1of 30 patients described by
Lurie (19), and transient loss of the radial pulse occurred in
1of 18 patients in the series of MacKay et al. (3). Among 16
patients cited by Leatherbury et al. (16), one death occurred
as a result of endomyocardial biopsy.
In the present study of 66 biopsy procedures in 53
patients, 1patient developed a pneumothorax 24 h later and
was treated with thoracostomy tube drainage. Perforation of
the right ventricular free wall occurred in three patients and
required pericardiocentesis in two and no intervention in
one. Thus, serious complications occurred during 3 (5%) of
the 66 procedures in this study. Ventricular tachycardia
developed in four patients and was self-limited in one and
readily controlled with lidocaine in the other three.
The success rate for endomyocardial biopsy in children
was 82% in the first reported series in 1977 (3). Since 1980,
however, the rate of successful procedures in children has
been 93% to 100% (6,8,13,15), and it was 96% in the present
study. Moreover, biopsy tissues provided diagnostic or
confirmatory information in 67% to 96% of the cases (Table
7) (3,6,15,16). Thus, when applied to infants, children and
adolescents, transvascular endomyocardial biopsy seems to
be a safe procedure that provides clinically useful informa-
tion in most cases. However, the risklbenefit ratio should be
assessed for patients on an individual basis.
As in adults, the procedure has been widely used for the
evaluation of acute cardiac allograft rejection and anthracy-
cline cardiotoxicity (9,13). It also has been an effective
diagnostic tool in children with unexplained arrhythmias,
muscular dystrophy, storage diseases, so-called oncocytic or
histiocytoid cardiomyopathy and cardiac tumors (3,8,23-29).
Endomyocardial biopsy has found its greatest application,
however, in the evaluation of cardiomyopathy and myo-
carditis (4-8,10-12,14-16,30,31).
Cardiomyopathy. Idiopathic dilated cardiomyopathy in
children is most commonly associated with congestive heart
failure and must be distinguished from other disorders of
known causes that produce similar features (32,33). In most
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Table 7. Reported Diagnostic Usefulness of Endomyocardial Biopsy in Infants, Children and Adolescents
Usefulness
Diagnoslic Confirmatory Not Useful
Reference Year No. % No. % No. % Total
MacKay et al. (3) 1977 3 20 7 47 5 33 15
Schmaltz et al. (6) 1982 2 14 10 72 2 14 14
Chandra (15) 1987 10 36 13 46 5 18 28·
Leatherbury et al. (16) 1988 8 40 7 35 5 25 20
Present study 1990 5 10 44 86 2 4 51t
"There were 28 biopsy procedures in 26 patients; tof the 53 patients, 2 had an unsuccessful procedure.
cases, biopsy tissues demonstrate myocyte hypertrophy and
interstitial fibrosis, thereby confirming a diagnosis of cardio-
myopathy; but these findings are nonspecific and do not
provide information concerning possible causes of the dis-
order (4,10,14-16).
Alternatively, myocarditis and endocardial fibroelastosis,
although they may mimic cardiomyopathy, are associated
with specific and diagnostic histopathologic lesions (34,35).
Certain storage diseases and mitochondrial disorders also
may produce congestive heart failure and mimic cardiomy-
opathy, but they are associated with specific diagnostic
features by transmission electron microscopy (27,28,36).
Hypertrophic and restrictive forms of cardiomyopathy in
infants and children have overlapping hemodynamic features
and may be difficult to differentiate in some patients (37,38).
Myocyte hypertrophy and interstitial fibrosis are the most
commonly observed microscopic findings in both disorders
and are nonspecific lesions. Myofiber disarray, a feature of
hypertrophic cardiomyopathy, may be limited to the core of
the ventricular septum and may be inaccessible to the
bioptome (39).
Transmission electron microscopy, however, has re-
vealed primary mitochondrial disease in one patient with a
clinical diagnosis of hypertrophic cardiomyopathy (16) and
unique abnormalities of the contractile elements in three
patients with restrictive hemodynamics (40,41). Cardiac
fibromas also may mimic hypertrophic cardiomyopathy (16).
Although the dilated, hypertrophic and restrictive forms
of cardiomyopathy have distinct clinical and autopsy fea-
tures, their biopsy findings are generally similar and nonspe-
cific (namely, hypertrophy and fibrosis). In some cases,
primary mitochondrial or myofibrillar disorders may be
observed by transmission electron microscopy, but such
findings usually do not alter therapeutic decisions.
Myocarditis. Myocarditis is an inflammatory disorder of
the myocardium that is characterized by a leukocytic infil-
trate and adjacent myocyte injury that is not due to ischemia
(20,21). Lymphocytic infiltrates that occur in areas of fi-
brosis without myocyte degeneration or necrosis should not
be misinterpreted as myocarditis (42).
In adults, there has been little correlation between clini-
cal and biopsy diagnoses of myocarditis (20), and this also
seems to be true for infants, children and adolescents.
Among 22 pediatric patients with a clinical diagnosis of
myocarditis accumulated from five reports (6,7,12,15,16),
biopsy features of myocarditis were observed in only 6
(27%). Similarly, in the present study, a tissue diagnosis of
myocarditis was rendered in only two (22%) of nine patients
who clinically were thought to have myocarditis.
Furthermore, among 73 pediatric patients with a clinical
diagnosis of dilated cardiomyopathy derived from six pub-
lished studies (4,6,10,14-16), myocarditis was observed in
biopsy specimens from 8 (11%). It also was diagnosed in one
patient who clinically had restrictive hemodynamics (15). In
the current investigation, myocarditis was present in 2 (25%)
of 8 patients with unexplained arrhythmias, but it was not
detected in any of the biopsy tissue samples from 25 patients
who clinically were thought to have idiopat~ic dilated car-
diomyopathy.
Whether myocarditis and dilated cardiomyopathy are
linked pathogenetically is a controversial topic (43,44). In
some cases, cardiomyopathy does seem to be the result of
inflammatory heart disease (44), but this is not necessarily
the most common scenario. It is possible that most cases of
myocarditis are self-limited and that most cases of dilated
cardiomyopathy are related to processes other than inflam-
mation.
No less controversial is whether patients with biopsy-
proved myocarditis should be treated with anti-inflammatory
or immunosuppressive drugs (45-48). Until the results of a
multicenter myocarditis trial (49,50) are available, it is our
opinion that caution should be exercised before subjecting
pediatric patients to endomyocardial biopsy procedures or to
potent drug regimens that have not yet been shown to be
efficacious.
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